Co-IP assays using antibody targeting endogenous or Flag-tagged HKDC1 showed that it could indeed interact with ACTA2, but not TUBA4A, in HCC cells (Fig. 4c and Supplementary Fig. 5a, b). This evidence concerns the gene ACTA2 and hepatocellular carcinoma.